US Stock MarketDetailed Quotes

KROS Keros Therapeutics

Watchlist
  • 18.830
  • +0.400+2.17%
Close Dec 13 16:00 ET
  • 18.640
  • -0.190-1.01%
Post 19:59 ET
762.75MMarket Cap-3.61P/E (TTM)

Keros Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
10.25%-30.5M
-29.09%-39.8M
-30.16%-44.56M
-77.71%-124.51M
-18.73%-25.46M
-38.13%-33.98M
-36.49%-30.83M
-2,299.09%-34.24M
-12.73%-70.06M
-9.60%-21.44M
Net income from continuing operations
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.8M
-78.20%-104.68M
-328.21%-29.72M
Operating gains losses
----
----
----
-66.67%4K
--0
--0
--0
--4K
-73.91%12K
-96.15%1K
Depreciation and amortization
49.52%314K
60.21%306K
65.87%277K
20.92%815K
94.49%247K
66.67%210K
-37.99%191K
47.79%167K
78.31%674K
22.12%127K
Other non cash items
65.10%563K
-2.26%346K
-35.06%339K
64.93%1.55M
4.36%335K
61.61%341K
71.84%354K
157.14%522K
80.96%941K
-64.61%321K
Change In working capital
435.49%12.76M
-336.04%-3.98M
-110.60%-10.13M
-118.52%-2.65M
123.31%6.88M
38.60%-3.8M
-44.46%-913K
-126.65%-4.81M
189.04%14.31M
118.16%3.08M
-Change in receivables
---384K
--222K
---83K
-100.79%-143K
---143K
--0
--0
--0
200.00%18M
--0
-Change in prepaid assets
237.86%5.87M
-327.54%-6.37M
-9.92%-4.48M
-179.55%-9.28M
299.63%539K
-1,584.32%-4.26M
63.70%-1.49M
-633.25%-4.07M
-114.53%-3.32M
-120.35%-270K
-Change in payables and accrued expense
7,631.52%7.11M
316.75%2.51M
-713.89%-5.33M
39.82%6.87M
40.61%6.83M
102.48%92K
-85.21%603K
-113.36%-655K
18.78%4.91M
569.15%4.86M
-Change in other current assets
--491K
----
----
69.63%-478K
---478K
--0
----
----
---1.57M
--0
-Change in other current liabilities
----
----
----
--0
----
----
----
----
--0
----
-Change in other working capital
-190.93%-331K
-1,100.00%-324K
-192.68%-240K
110.35%384K
108.55%129K
130.46%364K
95.54%-27K
79.60%-82K
-521.61%-3.71M
-51.71%-1.51M
Cash from discontinued investing activities
Operating cash flow
10.25%-30.5M
-29.09%-39.8M
-30.16%-44.56M
-77.71%-124.51M
-18.73%-25.46M
-38.13%-33.98M
-36.49%-30.83M
-2,299.09%-34.24M
-12.73%-70.06M
-9.60%-21.44M
Investing cash flow
Cash flow from continuing investing activities
29.82%-386K
0.32%-310K
10.92%-946K
-98.55%-2.46M
-54.13%-541K
-212.50%-550K
45.15%-311K
-622.45%-1.06M
-21.19%-1.24M
-120.75%-351K
Net PPE purchase and sale
29.82%-386K
0.32%-310K
10.92%-946K
-98.55%-2.46M
-54.13%-541K
-212.50%-550K
45.15%-311K
-622.45%-1.06M
-21.19%-1.24M
-120.75%-351K
Cash from discontinued investing activities
Investing cash flow
29.82%-386K
0.32%-310K
10.92%-946K
-98.55%-2.46M
-54.13%-541K
-212.50%-550K
45.15%-311K
-622.45%-1.06M
-21.19%-1.24M
-120.75%-351K
Financing cash flow
Cash flow from continuing financing activities
54,809.86%155.94M
102.93%3.53M
45.62%156.8M
48.75%178.96M
12.76%69.25M
-99.42%284K
-82.93%1.74M
91,152.54%107.68M
321.40%120.31M
116.13%61.42M
Net common stock issuance
--155.07M
--629K
41.03%151.34M
47.04%175.83M
11.59%68.52M
--0
--0
--107.31M
324.47%119.58M
117.96%61.4M
Proceeds from stock option exercised by employees
224.12%1.01M
70.52%2.97M
1,446.22%5.72M
294.25%3.23M
688.24%804K
223.96%311K
246.61%1.74M
213.56%370K
115.83%818K
-58.37%102K
Net other financing activities
---130K
---65K
---259K
-8.05%-94K
---67K
----
----
----
---87K
----
Cash from discontinued financing activities
Financing cash flow
54,809.86%155.94M
102.93%3.53M
45.62%156.8M
48.75%178.96M
12.76%69.25M
-99.42%284K
-82.93%1.74M
91,152.54%107.68M
321.40%120.31M
116.13%61.42M
Net cash flow
Beginning cash position
25.89%407.08M
25.77%443.66M
18.54%332.36M
21.18%280.38M
20.08%289.11M
49.05%323.35M
53.43%352.76M
21.18%280.38M
-13.02%231.37M
8.12%240.75M
Current changes in cash
465.15%125.06M
-24.41%-36.58M
53.76%111.3M
6.08%51.98M
9.17%43.25M
-243.87%-34.25M
-126.79%-29.4M
5,071.22%72.38M
241.55%49.01M
355.84%39.62M
End cash Position
84.06%532.13M
25.89%407.08M
25.77%443.66M
18.54%332.36M
18.54%332.36M
20.08%289.11M
49.05%323.35M
53.43%352.76M
21.18%280.38M
21.18%280.38M
Free cash flow
10.56%-30.89M
-28.80%-40.11M
-28.92%-45.51M
-78.07%-126.97M
-19.30%-26M
-39.37%-34.53M
-34.49%-31.14M
-2,142.50%-35.3M
-12.87%-71.3M
-10.49%-21.79M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 10.25%-30.5M-29.09%-39.8M-30.16%-44.56M-77.71%-124.51M-18.73%-25.46M-38.13%-33.98M-36.49%-30.83M-2,299.09%-34.24M-12.73%-70.06M-9.60%-21.44M
Net income from continuing operations -34.27%-52.96M-20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M-67.77%-39.44M-37.55%-37.51M-48.04%-35.8M-78.20%-104.68M-328.21%-29.72M
Operating gains losses -------------66.67%4K--0--0--0--4K-73.91%12K-96.15%1K
Depreciation and amortization 49.52%314K60.21%306K65.87%277K20.92%815K94.49%247K66.67%210K-37.99%191K47.79%167K78.31%674K22.12%127K
Other non cash items 65.10%563K-2.26%346K-35.06%339K64.93%1.55M4.36%335K61.61%341K71.84%354K157.14%522K80.96%941K-64.61%321K
Change In working capital 435.49%12.76M-336.04%-3.98M-110.60%-10.13M-118.52%-2.65M123.31%6.88M38.60%-3.8M-44.46%-913K-126.65%-4.81M189.04%14.31M118.16%3.08M
-Change in receivables ---384K--222K---83K-100.79%-143K---143K--0--0--0200.00%18M--0
-Change in prepaid assets 237.86%5.87M-327.54%-6.37M-9.92%-4.48M-179.55%-9.28M299.63%539K-1,584.32%-4.26M63.70%-1.49M-633.25%-4.07M-114.53%-3.32M-120.35%-270K
-Change in payables and accrued expense 7,631.52%7.11M316.75%2.51M-713.89%-5.33M39.82%6.87M40.61%6.83M102.48%92K-85.21%603K-113.36%-655K18.78%4.91M569.15%4.86M
-Change in other current assets --491K--------69.63%-478K---478K--0-----------1.57M--0
-Change in other current liabilities --------------0------------------0----
-Change in other working capital -190.93%-331K-1,100.00%-324K-192.68%-240K110.35%384K108.55%129K130.46%364K95.54%-27K79.60%-82K-521.61%-3.71M-51.71%-1.51M
Cash from discontinued investing activities
Operating cash flow 10.25%-30.5M-29.09%-39.8M-30.16%-44.56M-77.71%-124.51M-18.73%-25.46M-38.13%-33.98M-36.49%-30.83M-2,299.09%-34.24M-12.73%-70.06M-9.60%-21.44M
Investing cash flow
Cash flow from continuing investing activities 29.82%-386K0.32%-310K10.92%-946K-98.55%-2.46M-54.13%-541K-212.50%-550K45.15%-311K-622.45%-1.06M-21.19%-1.24M-120.75%-351K
Net PPE purchase and sale 29.82%-386K0.32%-310K10.92%-946K-98.55%-2.46M-54.13%-541K-212.50%-550K45.15%-311K-622.45%-1.06M-21.19%-1.24M-120.75%-351K
Cash from discontinued investing activities
Investing cash flow 29.82%-386K0.32%-310K10.92%-946K-98.55%-2.46M-54.13%-541K-212.50%-550K45.15%-311K-622.45%-1.06M-21.19%-1.24M-120.75%-351K
Financing cash flow
Cash flow from continuing financing activities 54,809.86%155.94M102.93%3.53M45.62%156.8M48.75%178.96M12.76%69.25M-99.42%284K-82.93%1.74M91,152.54%107.68M321.40%120.31M116.13%61.42M
Net common stock issuance --155.07M--629K41.03%151.34M47.04%175.83M11.59%68.52M--0--0--107.31M324.47%119.58M117.96%61.4M
Proceeds from stock option exercised by employees 224.12%1.01M70.52%2.97M1,446.22%5.72M294.25%3.23M688.24%804K223.96%311K246.61%1.74M213.56%370K115.83%818K-58.37%102K
Net other financing activities ---130K---65K---259K-8.05%-94K---67K---------------87K----
Cash from discontinued financing activities
Financing cash flow 54,809.86%155.94M102.93%3.53M45.62%156.8M48.75%178.96M12.76%69.25M-99.42%284K-82.93%1.74M91,152.54%107.68M321.40%120.31M116.13%61.42M
Net cash flow
Beginning cash position 25.89%407.08M25.77%443.66M18.54%332.36M21.18%280.38M20.08%289.11M49.05%323.35M53.43%352.76M21.18%280.38M-13.02%231.37M8.12%240.75M
Current changes in cash 465.15%125.06M-24.41%-36.58M53.76%111.3M6.08%51.98M9.17%43.25M-243.87%-34.25M-126.79%-29.4M5,071.22%72.38M241.55%49.01M355.84%39.62M
End cash Position 84.06%532.13M25.89%407.08M25.77%443.66M18.54%332.36M18.54%332.36M20.08%289.11M49.05%323.35M53.43%352.76M21.18%280.38M21.18%280.38M
Free cash flow 10.56%-30.89M-28.80%-40.11M-28.92%-45.51M-78.07%-126.97M-19.30%-26M-39.37%-34.53M-34.49%-31.14M-2,142.50%-35.3M-12.87%-71.3M-10.49%-21.79M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data